TRAIL acts mostly through the death receptor DR5, and it is a potent mediator of prominent neuronal loss induced in both chronic and acute neurodegenerative processes, including those related to brain ischemia (Martin-Villalba et al., 1999; Cantarella et al., 2014). The gene discussed is TNFSF10; the disease is brain ischemia.